Back to GetFilings.com




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2002

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission file number 1-5975


HUMANA INC.
(Exact name of registrant as specified in its charter)

Delaware

61-0647538

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification Number)



500 West Main Street
Louisville, Kentucky 40202

(Address of principal executive offices, including zip code)

(502) 580-1000
(Registrant's telephone number, including area code)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes X No ____

     
Indicate the number of shares outstanding of each of the issuer's classes of common stock as of the latest practicable date.

Class of Common Stock
$0.16 2/3 par value

Outstanding at
October 31, 2002
165,254,130 shares

 


Humana Inc.
FORM 10-Q
SEPTEMBER 30, 2002

INDEX

Part I: Financial Information

Page

Item 1.

Financial Statements

Condensed Consolidated Balance Sheets at September 30, 2002 and December 31, 2001

3

Condensed Consolidated Statements of Income for the three and nine months ended
   September 30, 2002 and 2001

4

Condensed Consolidated Statements of Cash Flows for the nine months ended
   September 30, 2002 and 2001

5

Notes to Condensed Consolidated Financial Statements

6

Item 2.

Management's Discussion and Analysis of Financial Condition and Results
   of Operations

15

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

32

Item 4.

Controls and Procedures

32

Part II: Other Information

Item 1.

Legal Proceedings

33

Item 6.

Exhibits and Reports on Form 8-K

36

Signatures

37

Certifications

38

2


Humana Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

September 30,

 

 

December 31,

 

 

 

2002


 

 

2001


 

 

 

(Unaudited)

 

 

(Audited)

 

 

 

(in thousands, except share amounts)

 

ASSETS

Current assets:

   Cash and cash equivalents

 

$

375,736

 

 

$

651,420

 

   Investment securities

 

 

1,420,524

 

 

 

1,389,596

 

   Receivables, less allowance for doubtful accounts of $32,606
      at September 30, 2002 and $38,539 at December 31, 2001:

 

 

 

 

 

 

 

 

      Premiums

 

 

489,518

 

 

 

299,601

 

      Administrative services fees

 

 

67,762

 

 

 

26,667

 

   Deferred income taxes

 

 

50,691

 

 

 

64,221

 

   Other

 

 

180,272

 

 

 

191,433

 



      Total current assets

 

 

2,584,503

 

 

 

2,622,938

 

Property and equipment, net

 

 

462,453

 

 

 

461,761

 

Other assets:

 

 

 

 

 

 

 

 

   Long-term investment securities

 

 

317,346

 

 

 

280,320

 

   Goodwill

 

 

776,874

 

 

 

776,874

 

   Deferred income taxes

 

 

147

 

 

 

36,582

 

   Other

 

 

238,007

 

 

 

225,163

 

 



      Total other assets

 

 

1,332,374

 

 

 

1,318,939

 

 

 


 

 


 

      Total assets

 

$

4,379,330

 

 

$

4,403,638

 



LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

   Medical and other expenses payable

 

$

1,164,431

 

 

$

1,086,386

 

   Trade accounts payable and accrued expenses

 

 

475,885

 

 

 

479,996

 

   Book overdraft

 

 

104,402

 

 

 

152,757

 

   Unearned premium revenues

 

 

89,977

 

 

 

325,040

 

   Short-term debt

 

 

265,000

 

 

 

263,000

 



      Total current liabilities

 

 

2,099,695

 

 

 

2,307,179

 

 

 

 

 

 

 

 

Long-term debt

 

 

334,061

 

 

 

315,489

 

Professional liability risks

 

 

247,690

 

 

 

241,431

 

Other long-term obligations

 

 

30,440

 

 

 

31,590

 



      Total liabilities

 

 

2,711,886

 

 

 

2,895,689

 



Commitments and contingencies

Stockholders' equity:

   Preferred stock, $1 par; 10,000,000 shares authorized, none issued

 

 

-

 

 

 

-

 

   Common stock, $0.16 2/3 par; 300,000,000 shares authorized;      171,303,567 shares issued in 2002 and 170,692,520 shares
     issued in 2001

 

 

28,551

 

 

 

28,449

 

   Capital in excess of par value

 

 

930,942

 

 

 

922,439

 

   Retained earnings

 

 

722,583

 

 

 

578,122

 

   Accumulated other comprehensive income

 

 

35,819

 

 

 

11,670

 

   Unearned stock compensation

 

 

(9,059

)

 

 

(17,882

)

   Treasury stock, at cost, 4,028,137 shares in 2002 and 1,880,619
     shares in 2001

 

 

(41,392

)

 

 

(14,849

)



      Total stockholders' equity

 

 

1,667,444

 

 

 

1,507,949

 



      Total liabilities and stockholders' equity

 

$

4,379,330

 

 

$

4,403,638

 



See accompanying notes to condensed consolidated financial statements.

3


Humana Inc.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

Three months ended
September 30,


Nine months ended
September 30,


2002


2001


2002


2001


(in thousands, except per share results)

Revenues:

  Premiums

$

2,752,336

$

2,541,483

$

8,137,887

$

7,394,575

  Administrative services fees

61,056

39,943

189,900

87,773

  Investment and other income

28,235

29,448

78,362

89,822





    Total revenues

2,841,627

2,610,874

8,406,149

7,572,170





Operating expenses:

  Medical

2,301,021

2,117,283

6,811,748

6,171,657

  Selling, general and administrative

429,019

398,799

1,278,516

1,132,660

  Depreciation and amortization

30,523

41,456

90,556

119,161





    Total operating expenses

2,760,563

2,557,538

8,180,820

7,423,478





Income from operations

81,064

53,336

225,329

148,692

Interest expense

4,107

5,945

12,888

20,468





Income before income taxes

76,957

47,391

212,441

128,224

Provision for income taxes

24,626

17,061

67,981

46,161





Net income

$

52,331

$

30,330

$

144,460

$

82,063





Basic earnings per common share

$

0.32

$

0.18

$

0.88

$

0.50





Diluted earnings per common share

$

0.31

$

0.18

$

0.86

$

0.49





See accompanying notes to condensed consolidated financial statements.

4


Humana Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

Nine months ended
September 30,


2002


2001


(in thousands)

Cash flows from operating activities

  Net income

$

144,460

$

82,063

  Adjustments to reconcile net income
    to net cash (used in) provided by operating activities:

      Depreciation and amortization

90,556

119,161

      Provision for deferred income taxes

34,221

40,288

      Payment for government audit settlement

-

(8,000

)

      Changes in operating assets and liabilities:

        Receivables

(231,012

)

14,251

        Other assets

268

13,839

        Medical and other expenses payable

78,045

(155,907

)

        Other liabilities

4,742

10,236

        Unearned premium revenues

(235,063

)

(55,491

)

      Other

12,481

(602

)



          Net cash (used in) provided by operating activities

(101,302

)

59,838



Cash flows from investing activities

  Acquisitions, net of cash and cash equivalents acquired

-

(32,700

)

  Divestitures, net of cash and cash equivalents disposed

1,109

1,050

  Purchases of property and equipment

(83,581

)

(82,173

)

  Purchases of investment securities

(1,639,803

)

(1,359,676

)

  Maturities of investment securities

273,199

421,498

  Proceeds from sales of investment securities

1,339,124

964,520



    Net cash used in investing activities

(109,952

)

(87,481

)



Cash flows from financing activities

  Net revolving credit agreement repayments

-

(250,000

)

  Net commercial paper conduit borrowings

2,000

-

  Net commercial paper repayments

-

(79,952

)

  Proceeds from issuance of senior notes

-

299,277

  Proceeds from other borrowings

-

5,700

  Debt issue costs

(559

)

(3,240

)

  Change in book overdraft

(48,355

)

(7,630

)

  Common stock repurchases

(25,439

)

(1,867

)

  Other

7,923

(374

)



    Net cash used in financing activities

(64,430

)

(38,086

)



Decrease in cash and cash equivalents

(275,684

)

(65,729

)

Cash and cash equivalents at beginning of period

651,420

657,562



Cash and cash equivalents at end of period

$

375,736

$

591,833



Supplemental cash flow disclosures:

  Interest payments

$

8,099

$

20,193

  Income tax payments, net

$

25,552

$

2,534

See accompanying notes to condensed consolidated financial statements.

5


Humana Inc.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited

 

(1)   Basis of Presentation

     The accompanying condensed consolidated financial statements are presented in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the disclosures normally required by accounting principles generally accepted in the United States of America, or those normally made in an Annual Report on Form 10-K. References throughout this document to "we," "us," "our," the "Company," and "Humana," mean Humana Inc. and all entities we own. For further information, the reader of this Form 10-Q should refer to our Form 10-K for the year ended December 31, 2001, that was filed with the Securities and Exchange Commission, or the SEC, on March 28, 2002, as well as the Form S-3 Registration Statement that we filed with the SEC on October 8, 2002.

     The preparation of our condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although our estimates are based on knowledge of current events and anticipated future events, actual results may ultimately differ materially from those estimates.

     The financial information has been prepared in accordance with our customary accounting practices and has not been audited. In our opinion, the information presented reflects all adjustments necessary for a fair statement of interim results. All such adjustments are of a normal and recurring nature. We have reclassified certain items in the prior year's condensed consolidated financial statements to conform with the current year presentation. These adjustments had no effect on previously reported consolidated net income or stockholders' equity.

     On January 1, 2002, we adopted Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, or Statement 144. Statement 144 develops a single accounting model for long-lived assets to be disposed of by sale, addresses significant implementation issues related to previous guidance, and requires that long-lived assets to be disposed of by sale be measured at the lower of their carrying amount or fair value less cost to sell, whether reported in continuing operations or in discontinued operations. The adoption of Statement No. 144 did not have a material impact on our financial position, results of operations or cash flows.

     The Financial Accounting Standards Board, or FASB, issued Statement of Financial Accounting Standards No. 146, or Statement 146, Accounting for Exit or Disposal Activities. Statement 146 addresses the recognition, measurement, and reporting of costs that are associated with exit and disposal activities, including certain lease termination costs and severance-type costs under a one-time benefit arrangement rather than an ongoing benefit arrangement or an individual deferred-compensation contract. Statement 146 requires liabilities associated with exit and disposal activities to be expensed as incurred and will impact the timing of recognition for exit or disposal activities that are initiated after December 31, 2002.

(2)   Goodwill and Other Intangible Assets

     In June 2001, the FASB issued Statement of Financial Accounting Standards No. 141, Business Combinations, or Statement 141, and Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets, or Statement 142. Statement 141 requires that all business combinations initiated after June 30, 2001 be accounted for using the purchase method. Use of the pooling-of-interest method is no longer permitted. Statement 142 requires that goodwill no longer be amortized to earnings, but instead be reviewed at least annually for impairment using a two-step process. The first step is a screen for potential impairment, and the second step measures the amount of impairment, if any. Impairment losses that arise from completing a transitional impairment test during 2002 are to be reported as the cumulative effect of a change in accounting principle at the beginning of the year. Subsequent impairments, if any, would be classified as an operating expense . Statement 142 also specifies the types of acquired intangible assets that are required to be recognized and reported separately from goodwill.

6


Humana Inc.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Unaudited

 

     We ceased amortizing goodwill upon adopting Statement 142 on January 1, 2002. We completed the transitional goodwill impairment test, which did not result in an impairment loss. Subsequent impairment tests will be performed, at a minimum, in the fourth quarter of each year in connection with the annual planning process. We allocated goodwill of $633.2 million to the Commercial segment and $143.7 million to the Government segment for purposes of completing the impairment test.

     The following table adjusts net income and basic and diluted earnings per common share for the three and nine months ended September 30, 2002 and 2001 to reflect the non-amortization of goodwill assuming the non-amortization provisions of Statement 142 were adopted as of January 1, 2001:

Three months ended
September 30,


Nine months ended
September 30,


2002


2001


2002


2001


(in thousands, except per share results)

Net income:

Reported net income

$

52,331

$

30,330

$

144,460

$

82,063

  Add back: goodwill amortization expense,
    net of tax

-

13,184

-

39,073





Adjusted net income

$

52,331

$

43,514

$

144,460

$

121,136





Basic earnings per common share:

Reported basic earnings per common share

$

0.32

$

0.18

$

0.88

$

0.50

  Add back: goodwill amortization expense,
    net of tax

-

0.08

-

0.24





Adjusted basic earnings per common share

$

0.32

$

0.27

$

0.88

$

0.74





Diluted earnings per common share:

Reported diluted earnings per common share

$

0.31

$

0.18

$

0.86

$

0.49

  Add back: goodwill amortization expense,
    net of tax

-

0.08

-

0.23





Adjusted diluted earnings per common share

$

0.31

$

0.26

$

0.86

$

0.73





 

      We amortize other intangible assets over their estimated useful lives ranging from 2 to 20 years, with a weighted average life of 8.6 years. Other intangible assets primarily relate to acquired subscriber, provider, and government contracts, and the cost of acquired licenses and are included with other long-term assets in the condensed consolidated balance sheets. Amortization expense for other intangible assets was approximately $3.9 million and $11.8 million for the three and nine months ended September 30, 2002, respectively, and $4.0 million and $9.4 million for the three and nine months ended September 30, 2001, respectively. The following table presents our estimate of amortization expense for all of 2002, and for each of the five succeeding fiscal years:

(in thousands)


For the years ended December 31:

  2002

$

15,724

  2003

$

11,612

  2004

$

9,060

  2005

$

5,440

  2006

$

352

  2007

$

352

7


Humana Inc.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
Unaudited

 

     The following table presents details of our other intangible assets at September 30, 2002 and December 31, 2001:

 

September 30, 2002


 

December 31, 2001


 

 

 

Accumulated

 

 

 

 

 

 

 

Accumulated

 

 

 

 

Cost


 

Amortization


 

Net


 

Cost


 

Amortization


 

Net


 

(in thousands)

Other intangible assets:

  Subscriber contracts

$

85,496

 

$

66,556

 

$

18,940

 

$

85,496

 

$

61,374

 

$

24,122

  Provider contracts

 

12,128

 

 

5,036

 

 

7,092

 

 

12,128

 

 

3,212

 

 

8,916

  Government contracts

 

11,820

 

 

8,222

 

 

3,598

 

 

11,820

 

 

3,597

 

 

8,223

  Licenses and other

 

5,065

 

 

1,107

 

 

3,958

 

 

5,065

 

 

945

 

 

4,120







   Total other intangible assets

$